Is GHRP-6 safe during pregnancy or breastfeeding?

GHRP-6, like most non-approved peptide therapeutics, does not have safety data supporting use during pregnancy or lactation. The default position is contraindication during pregnancy, lactation, and active conception, with discontinuation at least 2–3 cycles before planned conception. Approved indications (where they exist) may have specific guidance — verify with the prescribing physician.

What is the evidence base for GHRP-6?

GHRP-6's evidence base sits at research level investigational. The references on this page summarise 2 primary publications supporting the principal mechanism and applications. Where Phase II or Phase III human data exists for related indications, it is cited; where evidence is preclinical or limited to small case series, that is noted. The body composition / training interpretation respects the actual evidence tier rather than over-stating mechanistic plausibility.

What are the safety considerations for GHRP-6?

Marked appetite stimulation. Cortisol/prolactin elevation. Avoid if weight gain is undesirable. For anabolic and recovery use, additional considerations: baseline labs appropriate to the targeted system, mid-cycle re-check at 4–6 weeks, and end-of-cycle full re-evaluation. GHRP-6's ~15-30 min pharmacokinetic profile and subq administration route influence the side-effect profile in predictable ways.

How should GHRP-6 be stored and reconstituted?

Lyophilised GHRP-6 stores at −20°C for 18–24 months. After reconstitution with bacteriostatic water, the solution holds at 4°C for 14–28 days. Avoid freeze-thaw cycles of reconstituted material. Travel with cold packs in insulated containers; avoid prolonged exposure above 25°C. The standard reconstitution concentration is 1–2 mg/mL depending on the vial size.

What does GHRP-6 stack well with?

For body composition / training protocols, GHRP-6 pairs with compounds on complementary pathways: IGF-1 LR3, CJC-1295 + Ipamorelin Blend, TB-500. These pairings are selected because they engage independent receptor systems from GHRP-6's primary mechanism (Ghrelin-receptor agonist with the most pronounced effect on the central appetite circuit of any GHRP), producing additive or synergistic effects rather than receptor competition.

Should I cycle GHRP-6?

Standard cycle for GHRP-6 is 8–12 weeks of 2-3x daily subq 100-300 mcg dosing via subq, followed by a 4 week complete off-period. The off-period is calibrated to GHRP-6's ~15-30 min half-life and to typical receptor downregulation timelines. Continuous indefinite dosing does not show additional clinical benefit in the published literature and increases cumulative downregulation risk.

Home/ Compounds/ GHRP-6

GHRP-6

Body Composition

Athletes and performance coaches evaluating GHRP-6 for body composition focus on three measurable endpoints: lean mass, recovery capacity, and the rate of return to training intensity between sessions. Ghrelin-receptor agonist with the most pronounced effect on the central appetite circuit of any GHRP Stimulates GH release and concurrently increases hunger and gastric motility.. The 100-300 mcg 2-3x daily subq protocol over the standard 8-12 week cycle, paired with training stimulus and nutritional adequacy, is where the body-composition response is generated.

Body Composition / Training Applications

Training PerformanceLean MassFat LossWorkout RecoveryStrength

Key Takeaways

Body composition lens: response to GHRP-6 is proportional to training stimulus and nutritional adequacy.
Mechanism: Ghrelin-receptor agonist with the most pronounced effect on the central appetite circuit of any GHRP.
Body composition dose: 100-300 mcg 2-3x daily subq via subq; effects visible at week 4-8 with adequate training and protein.
Cycle structure: 8-12 weeks on, 4 weeks off; training-day or daily dosing depending on half-life.
Performance stack partners: IGF-1 LR3, CJC-1295 + Ipamorelin Blend, TB-500.

Body Composition / Training Mechanism

Ghrelin-receptor agonist with the most pronounced effect on the central appetite circuit of any GHRP. Stimulates GH release and concurrently increases hunger and gastric motility. Body composition relevance of this mechanism depends on which dimension of the anabolic cascade GHRP-6 engages: direct GH/IGF-axis activation, recovery-and-connective-tissue effects, or training-adjacent (sleep, inflammation) layers. The subsections below cover anabolic substrate, recovery window, training-day dosing, and hyperplasia versus hypertrophy.

Training-day versus rest-day dosing

Many peptides in this category respond better to training-day-only versus rest-day-included dosing. GHRP-6 with a ~15-30 min half-life of ~15-30 min is short-lived enough that timing relative to training sessions matters. The practical dosing schedule reflects this.

Hyperplasia and structural adaptation

Where GHRP-6 demonstrates effects on fibre count rather than fibre size — hyperplasia rather than hypertrophy — the structural adaptation matters more than the acute anabolic signal. Most peptides in this category contribute to the hypertrophic rather than hyperplastic adaptation, with the magnitude depending on training stimulus.

Anabolic substrate and protein synthesis

GHRP-6's relevance to body composition depends on where in the anabolic cascade it acts. It acts on adjacent rather than directly anabolic pathways, but the contribution to recovery, connective tissue, and inflammatory tone produces measurable body-composition effects in trained users. The downstream effect on body composition is dose- and training-dependent.

Body Composition / Training Applications

Body Recomposition

Body Recomposition responds to GHRP-6 with effect sizes proportional to training stimulus and nutritional adequacy. Users running aggressive caloric deficits see reduced response; users in surplus with adequate protein see proportionally larger response. Programming the inputs is half the protocol.

Tendon Repair

The body composition community converges on GHRP-6 for tendon repair with reported best-fit cycles of 8–12 weeks. Off-cycle of 4 weeks is standard. Stacking with complementary peptides on different pathways is the typical pattern for advanced users.

Fat Loss

For fat loss, GHRP-6 integrates with training programming on a per-session and per-cycle basis. Training-day dosing produces stronger acute effect; rest-day inclusion supports sustained baseline. The protocol pattern reflects training intensity and recovery demand.

Muscle Endurance

Muscle Endurance responds to GHRP-6 with effect sizes proportional to training stimulus and nutritional adequacy. Users running aggressive caloric deficits see reduced response; users in surplus with adequate protein see proportionally larger response. Programming the inputs is half the protocol.

Dosing Protocol

Goal	Route	Dose	Cycle
Standard protocol	SubQ	100-300 mcg	8–12 weeks on / 4 weeks off
Conservative starter	SubQ	60-300 mcg	4–6 weeks initial cycle
Body Composition focus	SubQ	100-300 mcg	2-3x daily SubQ
Maintenance phase	SubQ	70-300 mcg	Ongoing with periodic pauses

Dose timing for GHRP-6 is important relative to food and training given the short half-life. Consistency through the cycle is more important than the precise clock time of individual doses.

Stacking

GHRP-6 stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from performance coaches and athletes.

GHRP-6 + IGF-1 LR3: Binds the IGF-1 receptor with full agonist activity. Pairs naturally with GHRP-6's mechanism in body composition / training protocols.
GHRP-6 + CJC-1295 + Ipamorelin Blend: CJC-1295 stimulates the GHRH receptor; ipamorelin stimulates the ghrelin/GHSR receptor. Pairs naturally with GHRP-6's mechanism in body composition / training protocols.
GHRP-6 + TB-500: Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool. Pairs naturally with GHRP-6's mechanism in body composition / training protocols.
GHRP-6 + BPC-157: Upregulates VEGFR2 to promote angiogenesis and activates the FAK-paxillin pathway for accelerated tissue repair. Pairs naturally with GHRP-6's mechanism in body composition / training protocols.

Safety & Regulatory Status

WADA: Banned (S2) FDA: Unapproved

Marked appetite stimulation. Cortisol/prolactin elevation. Avoid if weight gain is undesirable.

Lens-specific safety considerations for body composition / training use of GHRP-6: Marked appetite stimulation. Cortisol/prolactin elevation. Avoid if weight gain is undesirable. Additional body composition / training monitoring at baseline and 6–8 week follow-up is appropriate.

Clinical Evidence

Primary

GHRP-6 — appetite and GH release

PMID 1518370

Supporting

Ghrelin receptor and GHRP-6 mechanism

PMID 11717269

GHRP-6 vs Related Peptides

Compound	Profile	Onset	Best For
GHRP-6	Growth hormone releasing peptide	~15-30 min	Body Composition
IGF-1 LR3	Modified insulin-like growth factor 1	~20-30 hr (vs ~10 min for native IGF-1)	A modified IGF-1 with a 13-amino-acid N-terminal extension and Arg substitution that resists IGFBP binding — extending half-life from 10 minutes to roughly a day
Tesamorelin	Stabilised GHRH analogue	~30 min	An FDA-approved long-chain GHRH analogue used for HIV-associated lipodystrophy and notable for its consistent effect on visceral adipose reduction
Ipamorelin	Selective GHRP / ghrelin mimetic	~2 hr	The most selective ghrelin-receptor agonist among the GHRPs — stimulates GH release with minimal effect on cortisol, prolactin, or appetite

Frequently Asked Questions

Will GHRP-6 affect my training performance?

Most commonly via faster recovery between sessions, which permits higher training frequency and intensity. Acute performance-enhancing effects in a single session are not the typical profile. Users typically need to upregulate nutrition and adjust programming to take advantage of the increased recovery capacity.

How does GHRP-6 compare to AAS for body composition?

Peptide therapeutics including GHRP-6 produce more modest body composition shifts than anabolic-androgenic steroids and operate on different mechanisms with substantially different side-effect profiles. The compound is most-appropriate for users prioritising long-term sustainability and clean blood work over maximum acute mass.

Best stack pairing for lean mass?

The canonical lean mass stack pairs GHRP-6 with a complementary GH-axis component, a connective-tissue support peptide, and — in advanced protocols — an anabolic-supportive component. Specific pairings depend on which dimension of body composition is prioritised: pure mass, mass-and-fat-loss, or recovery-focused.

Training-day only or daily dosing?

For most peptide compounds with short-to-moderate half-life, training-day dosing produces stronger acute effect; rest-day inclusion supports sustained baseline. The choice depends on the user's training volume and the compound's pharmacokinetics. Daily dosing for 4-7 days is the default; training-day-only protocols are appropriate for lower-volume programmes.

What is the mechanism of action of GHRP-6?

Ghrelin-receptor agonist with the most pronounced effect on the central appetite circuit of any GHRP. Stimulates GH release and concurrently increases hunger and gastric motility. For anabolic and recovery applications specifically, the relevant downstream consequence is the cascade from receptor engagement to systemic effect: Ghrelin-receptor agonist with the most pronounced effect on the central appetite circuit of any GHRP. The body composition / training interpretation focuses on the pathway-level detail rather than on any single high-level summary.

What route should I use for GHRP-6?

GHRP-6 is delivered by subq. Subcutaneous administration is standard for ${o.cat.toLowerCase()} class peptides and provides reliable systemic bioavailability. The choice depends on target system and convenience.

Clinical Protocol

Start a GHRP-6 Protocol

Alukard provides physician-supervised body composition protocols with GMP-certified GHRP-6 and GMP-certified compounds and training-aware dosing guidance.

Get Protocol

Quick Facts

Molecular weight: 873 Da
Sequence length: 6 aa
Half-life: ~15-30 min
WADA: Banned (S2)
FDA: Unapproved

Stack Partners

IGF-1 LR3

CJC-1295 + Ipamorelin Blend

TB-500

BPC-157

Tesamorelin + Ipamorelin Blend

Research Note

All body composition / training applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for GHRP-6 unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.

Physician-supervised body composition protocols

Start Your Body Composition / Training Protocol for GHRP-6

Alukard provides physician-supervised body composition protocols with GMP-certified compounds and training-aware dosing guidance.

Get a Physician Consultation View All Compounds

HIPAA Compliant · GMP Certified · Physician Supervised